FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2413663150> ?p ?o ?g. }

• W2413663150 abstract "Natalizumab is a monoclonal antibody that significantly reduces the occurrence of relapses in relapse-remitting multiple sclerosis (RRMS) patients. Early papers on the clinical use of natalizumab in RRMS patients reported erythroblastemia as occasional and transient.to determine the prevalence and absolute count of erythroblasts (nucleated red blood cells, NRBCs) in peripheral blood of RRMS patients in different treatment groups and healthy controls from the same geographic area using the same equipment for laboratory analysis.We retrospectively evaluated the samples of 203 consecutive RRMS patients including 26 subjects on natalizumab, 17 on fingolimod, 72 on interferon, 41 on glatiramer acetate, 47 treatment-naïve and 240 healthy controls from the same geographic area. Blood samples were processed using an XN-9000-Hematology Analyzer and subsequent microscopic verification. In the natalizumab-treated patients we performed an additional analysis in order to detect the expression of CD34+ cells in peripheral blood, as confirmation of a bone marrow mobilization.The prevalence of patients with NRBCs positivity was significantly higher in natalizumab-treated patients (92%) compared with the other treatment groups and healthy controls (0%) (p<0.0005). The median absolute NRBCs count was significantly higher in natalizumab-treated patients (median 0.020, p<0.0005) than in the other treatment groups and healthy controls. Natalizumab-treated patients also had higher levels of white blood cells than all other groups and lower haemoglobin levels than healthy subjects (p<0.01), but no morphologic alterations were evident at a subsequent review of red blood cells, platelets and white blood cells. CD34+ cells levels were consistent with mobilization of haematopoietic stem cells from the bone marrow (median 8 cells/µL, IQR 5-12).We confirm erythroblastaemia as a frequent finding of natalizumab treatment in RRMS patients. More extended knowledge and adequate long-term observation of this phenomenon are essential to better understand any pathological implication." @default.
• W2413663150 created "2016-06-24" @default.
• W2413663150 creator A5001437313 @default.
• W2413663150 creator A5015829572 @default.
• W2413663150 creator A5040071369 @default.
• W2413663150 creator A5046783508 @default.
• W2413663150 creator A5046803676 @default.
• W2413663150 creator A5057103257 @default.
• W2413663150 creator A5059508536 @default.
• W2413663150 creator A5062101573 @default.
• W2413663150 creator A5081203047 @default.
• W2413663150 creator A5085120663 @default.
• W2413663150 creator A5085368889 @default.
• W2413663150 date "2016-07-01" @default.
• W2413663150 modified "2023-09-27" @default.
• W2413663150 title "Erythroblastaemia in natalizumab-treated patients with multiple sclerosis" @default.
• W2413663150 cites W1532162953 @default.
• W2413663150 cites W1964291413 @default.
• W2413663150 cites W1974438776 @default.
• W2413663150 cites W1976744213 @default.
• W2413663150 cites W1983890885 @default.
• W2413663150 cites W1986002079 @default.
• W2413663150 cites W1989037087 @default.
• W2413663150 cites W2011500179 @default.
• W2413663150 cites W2025031772 @default.
• W2413663150 cites W2097326170 @default.
• W2413663150 cites W2103758700 @default.
• W2413663150 cites W2106467284 @default.
• W2413663150 cites W2146776050 @default.
• W2413663150 cites W2148520801 @default.
• W2413663150 cites W2169543796 @default.
• W2413663150 cites W2200094544 @default.
• W2413663150 cites W2327625073 @default.
• W2413663150 cites W2341818685 @default.
• W2413663150 cites W2593173846 @default.
• W2413663150 doi "https://doi.org/10.1016/j.msard.2016.05.020" @default.
• W2413663150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27456890" @default.
• W2413663150 hasPublicationYear "2016" @default.
• W2413663150 type Work @default.
• W2413663150 sameAs 2413663150 @default.
• W2413663150 citedByCount "5" @default.
• W2413663150 countsByYear W24136631502017 @default.
• W2413663150 countsByYear W24136631502019 @default.
• W2413663150 countsByYear W24136631502020 @default.
• W2413663150 crossrefType "journal-article" @default.
• W2413663150 hasAuthorship W2413663150A5001437313 @default.
• W2413663150 hasAuthorship W2413663150A5015829572 @default.
• W2413663150 hasAuthorship W2413663150A5040071369 @default.
• W2413663150 hasAuthorship W2413663150A5046783508 @default.
• W2413663150 hasAuthorship W2413663150A5046803676 @default.
• W2413663150 hasAuthorship W2413663150A5057103257 @default.
• W2413663150 hasAuthorship W2413663150A5059508536 @default.
• W2413663150 hasAuthorship W2413663150A5062101573 @default.
• W2413663150 hasAuthorship W2413663150A5081203047 @default.
• W2413663150 hasAuthorship W2413663150A5085120663 @default.
• W2413663150 hasAuthorship W2413663150A5085368889 @default.
• W2413663150 hasConcept C126322002 @default.
• W2413663150 hasConcept C203014093 @default.
• W2413663150 hasConcept C2776036978 @default.
• W2413663150 hasConcept C2778577042 @default.
• W2413663150 hasConcept C2780007613 @default.
• W2413663150 hasConcept C2780640218 @default.
• W2413663150 hasConcept C2781004633 @default.
• W2413663150 hasConcept C3017910909 @default.
• W2413663150 hasConcept C71924100 @default.
• W2413663150 hasConcept C90924648 @default.
• W2413663150 hasConceptScore W2413663150C126322002 @default.
• W2413663150 hasConceptScore W2413663150C203014093 @default.
• W2413663150 hasConceptScore W2413663150C2776036978 @default.
• W2413663150 hasConceptScore W2413663150C2778577042 @default.
• W2413663150 hasConceptScore W2413663150C2780007613 @default.
• W2413663150 hasConceptScore W2413663150C2780640218 @default.
• W2413663150 hasConceptScore W2413663150C2781004633 @default.
• W2413663150 hasConceptScore W2413663150C3017910909 @default.
• W2413663150 hasConceptScore W2413663150C71924100 @default.
• W2413663150 hasConceptScore W2413663150C90924648 @default.
• W2413663150 hasLocation W24136631501 @default.
• W2413663150 hasLocation W24136631502 @default.
• W2413663150 hasOpenAccess W2413663150 @default.
• W2413663150 hasPrimaryLocation W24136631501 @default.
• W2413663150 isParatext "false" @default.
• W2413663150 isRetracted "false" @default.
• W2413663150 magId "2413663150" @default.
• W2413663150 workType "article" @default.